Immune-Modulating Dual-Targeted Nanomaterials for Low-Temperature Photothermal-Photodynamic-Chemodynamic Therapy of Osteosarcoma Targeting Tumor and Endothelial Cells.

ACS Nano · 2025 · PMC12410057 · PMID 40834268

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Therefore, RRM2 could be a highly significant target for simultaneously inhibiting the malignant proliferation of both osteosarcoma cells and osteosarcoma-associated heterogeneous endothelial cells.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.